- Home
- OGI vs JYNT Comparison
OGI vs JYNT Comparison
Compare OGI & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- JYNT
- Stock Information
- Founded
- OGI 2013
- JYNT 2010
- Country
- OGI Canada
- JYNT United States
- Employees
- OGI N/A
- JYNT N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- JYNT Multi-Sector Companies
- Sector
- OGI Health Care
- JYNT Miscellaneous
- Exchange
- OGI Nasdaq
- JYNT Nasdaq
- Market Cap
- OGI 200.6M
- JYNT 154.2M
- IPO Year
- OGI N/A
- JYNT 2014
- Fundamental
- Price
- OGI $1.53
- JYNT $10.22
- Analyst Decision
- OGI
- JYNT Strong Buy
- Analyst Count
- OGI 0
- JYNT 2
- Target Price
- OGI N/A
- JYNT $17.50
- AVG Volume (30 Days)
- OGI 820.8K
- JYNT 50.4K
- Earning Date
- OGI 02-11-2025
- JYNT 03-06-2025
- Dividend Yield
- OGI N/A
- JYNT N/A
- EPS Growth
- OGI N/A
- JYNT N/A
- EPS
- OGI N/A
- JYNT N/A
- Revenue
- OGI $118,317,480.00
- JYNT $120,795,620.00
- Revenue This Year
- OGI $57.65
- JYNT $3.28
- Revenue Next Year
- OGI $10.93
- JYNT N/A
- P/E Ratio
- OGI N/A
- JYNT N/A
- Revenue Growth
- OGI 0.69
- JYNT 5.26
- 52 Week Low
- OGI $1.31
- JYNT $8.94
- 52 Week High
- OGI $2.91
- JYNT $17.82
- Technical
- Relative Strength Index (RSI)
- OGI 44.32
- JYNT 42.53
- Support Level
- OGI $1.56
- JYNT $9.98
- Resistance Level
- OGI $1.77
- JYNT $10.81
- Average True Range (ATR)
- OGI 0.08
- JYNT 0.43
- MACD
- OGI -0.00
- JYNT 0.02
- Stochastic Oscillator
- OGI 11.11
- JYNT 50.00
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.